Vineeta Belanger
Chief Tech/Sci/R&D Officer bei LYRA THERAPEUTICS, INC.
Profil
Dr. Vineeta Belanger is a Senior Vice President-Clinical Affairs at Lyra Therapeutics, Inc. Dr. Belanger was previously employed as a Vice President-Clinical Affairs by Avedro, Inc. and a Principal by Ironwood Pharmaceuticals, Inc. She received her undergraduate degree from All India Institute of Medical Sciences and a doctorate degree from the University of Houston.
Aktive Positionen von Vineeta Belanger
| Unternehmen | Position | Beginn |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.09.2019 |
Ehemalige bekannte Positionen von Vineeta Belanger
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AVEDRO, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Vineeta Belanger
| University of Houston | Doctorate Degree |
| All India Institute of Medical Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
